1 Scope of the Report
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats
2 Executive Summary
2.1 World Market Overview
2.1.1 Global Leukotriene Modifiers Annual Sales 2018-2029
2.1.2 World Current & Future Analysis for Leukotriene Modifiers by Geographic Region, 2018, 2022 & 2029
2.1.3 World Current & Future Analysis for Leukotriene Modifiers by Country/Region, 2018, 2022 & 2029
2.2 Leukotriene Modifiers Segment by Type
2.2.1 Tablets
2.2.2 Chewable Tablets
2.2.3 Oral Granules
2.3 Leukotriene Modifiers Sales by Type
2.3.1 Global Leukotriene Modifiers Sales Market Share by Type (2018-2023)
2.3.2 Global Leukotriene Modifiers Revenue and Market Share by Type (2018-2023)
2.3.3 Global Leukotriene Modifiers Sale Price by Type (2018-2023)
2.4 Leukotriene Modifiers Segment by Application
2.4.1 Hospitals Pharmacies
2.4.2 Retail Pharmacies
2.4.3 Drug Stores
2.4.4 Online Pharmacies
2.5 Leukotriene Modifiers Sales by Application
2.5.1 Global Leukotriene Modifiers Sale Market Share by Application (2018-2023)
2.5.2 Global Leukotriene Modifiers Revenue and Market Share by Application (2018-2023)
2.5.3 Global Leukotriene Modifiers Sale Price by Application (2018-2023)
3 Global Leukotriene Modifiers by Company
3.1 Global Leukotriene Modifiers Breakdown Data by Company
3.1.1 Global Leukotriene Modifiers Annual Sales by Company (2018-2023)
3.1.2 Global Leukotriene Modifiers Sales Market Share by Company (2018-2023)
3.2 Global Leukotriene Modifiers Annual Revenue by Company (2018-2023)
3.2.1 Global Leukotriene Modifiers Revenue by Company (2018-2023)
3.2.2 Global Leukotriene Modifiers Revenue Market Share by Company (2018-2023)
3.3 Global Leukotriene Modifiers Sale Price by Company
3.4 Key Manufacturers Leukotriene Modifiers Producing Area Distribution, Sales Area, Product Type
3.4.1 Key Manufacturers Leukotriene Modifiers Product Location Distribution
3.4.2 Players Leukotriene Modifiers Products Offered
3.5 Market Concentration Rate Analysis
3.5.1 Competition Landscape Analysis
3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2018-2023)
3.6 New Products and Potential Entrants
3.7 Mergers & Acquisitions, Expansion
4 World Historic Review for Leukotriene Modifiers by Geographic Region
4.1 World Historic Leukotriene Modifiers Market Size by Geographic Region (2018-2023)
4.1.1 Global Leukotriene Modifiers Annual Sales by Geographic Region (2018-2023)
4.1.2 Global Leukotriene Modifiers Annual Revenue by Geographic Region (2018-2023)
4.2 World Historic Leukotriene Modifiers Market Size by Country/Region (2018-2023)
4.2.1 Global Leukotriene Modifiers Annual Sales by Country/Region (2018-2023)
4.2.2 Global Leukotriene Modifiers Annual Revenue by Country/Region (2018-2023)
4.3 Americas Leukotriene Modifiers Sales Growth
4.4 APAC Leukotriene Modifiers Sales Growth
4.5 Europe Leukotriene Modifiers Sales Growth
4.6 Middle East & Africa Leukotriene Modifiers Sales Growth
5 Americas
5.1 Americas Leukotriene Modifiers Sales by Country
5.1.1 Americas Leukotriene Modifiers Sales by Country (2018-2023)
5.1.2 Americas Leukotriene Modifiers Revenue by Country (2018-2023)
5.2 Americas Leukotriene Modifiers Sales by Type
5.3 Americas Leukotriene Modifiers Sales by Application
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Leukotriene Modifiers Sales by Region
6.1.1 APAC Leukotriene Modifiers Sales by Region (2018-2023)
6.1.2 APAC Leukotriene Modifiers Revenue by Region (2018-2023)
6.2 APAC Leukotriene Modifiers Sales by Type
6.3 APAC Leukotriene Modifiers Sales by Application
6.4 China
6.5 Japan
6.6 South Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
6.10 China Taiwan
7 Europe
7.1 Europe Leukotriene Modifiers by Country
7.1.1 Europe Leukotriene Modifiers Sales by Country (2018-2023)
7.1.2 Europe Leukotriene Modifiers Revenue by Country (2018-2023)
7.2 Europe Leukotriene Modifiers Sales by Type
7.3 Europe Leukotriene Modifiers Sales by Application
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 Middle East & Africa
8.1 Middle East & Africa Leukotriene Modifiers by Country
8.1.1 Middle East & Africa Leukotriene Modifiers Sales by Country (2018-2023)
8.1.2 Middle East & Africa Leukotriene Modifiers Revenue by Country (2018-2023)
8.2 Middle East & Africa Leukotriene Modifiers Sales by Type
8.3 Middle East & Africa Leukotriene Modifiers Sales by Application
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 Market Drivers, Challenges and Trends
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 Manufacturing Cost Structure Analysis
10.1 Raw Material and Suppliers
10.2 Manufacturing Cost Structure Analysis of Leukotriene Modifiers
10.3 Manufacturing Process Analysis of Leukotriene Modifiers
10.4 Industry Chain Structure of Leukotriene Modifiers
11 Marketing, Distributors and Customer
11.1 Sales Channel
11.1.1 Direct Channels
11.1.2 Indirect Channels
11.2 Leukotriene Modifiers Distributors
11.3 Leukotriene Modifiers Customer
12 World Forecast Review for Leukotriene Modifiers by Geographic Region
12.1 Global Leukotriene Modifiers Market Size Forecast by Region
12.1.1 Global Leukotriene Modifiers Forecast by Region (2024-2029)
12.1.2 Global Leukotriene Modifiers Annual Revenue Forecast by Region (2024-2029)
12.2 Americas Forecast by Country
12.3 APAC Forecast by Region
12.4 Europe Forecast by Country
12.5 Middle East & Africa Forecast by Country
12.6 Global Leukotriene Modifiers Forecast by Type
12.7 Global Leukotriene Modifiers Forecast by Application
13 Key Players Analysis
13.1 AstraZeneca PLC
13.1.1 AstraZeneca PLC Company Information
13.1.2 AstraZeneca PLC Leukotriene Modifiers Product Portfolios and Specifications
13.1.3 AstraZeneca PLC Leukotriene Modifiers Sales, Revenue, Price and Gross Margin (2018-2023)
13.1.4 AstraZeneca PLC Main Business Overview
13.1.5 AstraZeneca PLC Latest Developments
13.2 GlaxoSmithKline
13.2.1 GlaxoSmithKline Company Information
13.2.2 GlaxoSmithKline Leukotriene Modifiers Product Portfolios and Specifications
13.2.3 GlaxoSmithKline Leukotriene Modifiers Sales, Revenue, Price and Gross Margin (2018-2023)
13.2.4 GlaxoSmithKline Main Business Overview
13.2.5 GlaxoSmithKline Latest Developments
13.3 Chiesi Farmaceutici
13.3.1 Chiesi Farmaceutici Company Information
13.3.2 Chiesi Farmaceutici Leukotriene Modifiers Product Portfolios and Specifications
13.3.3 Chiesi Farmaceutici Leukotriene Modifiers Sales, Revenue, Price and Gross Margin (2018-2023)
13.3.4 Chiesi Farmaceutici Main Business Overview
13.3.5 Chiesi Farmaceutici Latest Developments
13.4 Merck
13.4.1 Merck Company Information
13.4.2 Merck Leukotriene Modifiers Product Portfolios and Specifications
13.4.3 Merck Leukotriene Modifiers Sales, Revenue, Price and Gross Margin (2018-2023)
13.4.4 Merck Main Business Overview
13.4.5 Merck Latest Developments
13.5 Starallergens Greer
13.5.1 Starallergens Greer Company Information
13.5.2 Starallergens Greer Leukotriene Modifiers Product Portfolios and Specifications
13.5.3 Starallergens Greer Leukotriene Modifiers Sales, Revenue, Price and Gross Margin (2018-2023)
13.5.4 Starallergens Greer Main Business Overview
13.5.5 Starallergens Greer Latest Developments
13.6 Sumitomo Dainippon Pharma
13.6.1 Sumitomo Dainippon Pharma Company Information
13.6.2 Sumitomo Dainippon Pharma Leukotriene Modifiers Product Portfolios and Specifications
13.6.3 Sumitomo Dainippon Pharma Leukotriene Modifiers Sales, Revenue, Price and Gross Margin (2018-2023)
13.6.4 Sumitomo Dainippon Pharma Main Business Overview
13.6.5 Sumitomo Dainippon Pharma Latest Developments
13.7 Circassia Pharmaceuticals
13.7.1 Circassia Pharmaceuticals Company Information
13.7.2 Circassia Pharmaceuticals Leukotriene Modifiers Product Portfolios and Specifications
13.7.3 Circassia Pharmaceuticals Leukotriene Modifiers Sales, Revenue, Price and Gross Margin (2018-2023)
13.7.4 Circassia Pharmaceuticals Main Business Overview
13.7.5 Circassia Pharmaceuticals Latest Developments
13.8 Apotex Holdings
13.8.1 Apotex Holdings Company Information
13.8.2 Apotex Holdings Leukotriene Modifiers Product Portfolios and Specifications
13.8.3 Apotex Holdings Leukotriene Modifiers Sales, Revenue, Price and Gross Margin (2018-2023)
13.8.4 Apotex Holdings Main Business Overview
13.8.5 Apotex Holdings Latest Developments
13.9 Teva Pharmaceutical Industries
13.9.1 Teva Pharmaceutical Industries Company Information
13.9.2 Teva Pharmaceutical Industries Leukotriene Modifiers Product Portfolios and Specifications
13.9.3 Teva Pharmaceutical Industries Leukotriene Modifiers Sales, Revenue, Price and Gross Margin (2018-2023)
13.9.4 Teva Pharmaceutical Industries Main Business Overview
13.9.5 Teva Pharmaceutical Industries Latest Developments
13.10 Torrent Pharmaceuticals
13.10.1 Torrent Pharmaceuticals Company Information
13.10.2 Torrent Pharmaceuticals Leukotriene Modifiers Product Portfolios and Specifications
13.10.3 Torrent Pharmaceuticals Leukotriene Modifiers Sales, Revenue, Price and Gross Margin (2018-2023)
13.10.4 Torrent Pharmaceuticals Main Business Overview
13.10.5 Torrent Pharmaceuticals Latest Developments
13.11 annett Company
13.11.1 annett Company Company Information
13.11.2 annett Company Leukotriene Modifiers Product Portfolios and Specifications
13.11.3 annett Company Leukotriene Modifiers Sales, Revenue, Price and Gross Margin (2018-2023)
13.11.4 annett Company Main Business Overview
13.11.5 annett Company Latest Developments
13.12 Novartis
13.12.1 Novartis Company Information
13.12.2 Novartis Leukotriene Modifiers Product Portfolios and Specifications
13.12.3 Novartis Leukotriene Modifiers Sales, Revenue, Price and Gross Margin (2018-2023)
13.12.4 Novartis Main Business Overview
13.12.5 Novartis Latest Developments
13.13 Aurobindo Pharma
13.13.1 Aurobindo Pharma Company Information
13.13.2 Aurobindo Pharma Leukotriene Modifiers Product Portfolios and Specifications
13.13.3 Aurobindo Pharma Leukotriene Modifiers Sales, Revenue, Price and Gross Margin (2018-2023)
13.13.4 Aurobindo Pharma Main Business Overview
13.13.5 Aurobindo Pharma Latest Developments
14 Research Findings and Conclusion
| ※参考情報 ロイコトリエン修飾剤は、主に喘息やアレルギー性鼻炎などの呼吸器疾患の治療に使用される薬剤です。これらの薬剤は、ロイコトリエンという生理活性物質の作用を調節することによって、気道の炎症や狭窄を抑える役割を持っています。 ロイコトリエンは、特に好中球やマスト細胞、マクロファージなどの細胞から生成され、アレルギー反応や炎症に関与しています。これらの物質は、平滑筋の収縮や血管透過性の増加、白血球の浸潤などを引き起こし、結果として喘息発作やアレルギー症状を引き起こします。したがって、ロイコトリエン修飾剤はこれらの作用を阻害することで、症状の軽減や予防を図ります。 ロイコトリエン修飾剤の特徴としては、経口投与が可能である点があります。このため、吸入剤に比べて患者の服用遵守がしやすい特徴があります。また、長時間作用するため、効果が持続するのも利点の一つです。副作用が比較的少ないため、多くの患者に適用できることも考慮されますが、使用に当たっては医師の指導が必要です。 ロイコトリエン修飾剤にはいくつかの種類があります。代表的なものには、モンテルカスト（Montelukast）、ザフィルルカスト（Zafirlukast）、プランルカスト（Pranlukast）などがあります。モンテルカストは特に広く使用されており、様々な年齢層においても利用可能で、アレルギー性鼻炎の治療にも効果があります。 用途に関しては、喘息のコントロールだけでなく、季節性鼻炎や通年性アレルギーの治療にも用いられます。また、運動誘発性喘息の予防にも使われることがあります。そのため、これらの薬剤は、喘息を有する患者の生活の質を向上させる手段として重要な位置を占めています。 関連技術としては、ロイコトリエンの生成を抑える食事や生活習慣の変更が挙げられます。例えば、オメガ3脂肪酸を多く含む食品の摂取や、ストレス管理、適切な運動がロイコトリエンの生成に影響を与えることが示されています。加えて、最近の研究では、マイクロバイオームと呼ばれる腸内細菌叢が、アレルギー反応に関連していることも報告されており、これらをターゲットにした新しい治療方法の開発が期待されています。 ロイコトリエン修飾剤は、医療現場において重要な役割を果たす薬剤であり、今後もその研究が進むことで、より効果的な治療法や用途が見出されることが期待されます。喘息やアレルギー疾患を抱える患者が、より健康的な生活を送るための手助けとして、これらの薬剤が今後も利用されていくことでしょう。 |
